FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051310287> ?p ?o ?g. }

• W2051310287 endingPage "1410" @default.
• W2051310287 startingPage "1401" @default.
• W2051310287 abstract "Antibody engineering has made it possible to design antibodies with optimal characteristics for delivery of radionuclides for tumour imaging and therapy. A humanised divalent-Fab′ cross-linked with a bis-maleimide linker referred to as humanised divalent-Fab′ maleimide was produced as a result of this design process. It is a humanised divalent antibody with no Fc, which can be produced in bacteria and has enhanced stability compared with F(ab′)2. Here we describe a clinical study in patients with colorectal cancer using humanised divalent-Fab′ maleimide generated from the anti-carcinoembryonic antigen antibody A5B7 radiolabelled with iodine-131. Ten patients received an i.v. injection of iodine-131-labelled A5B7 humanised divalent-Fab′ maleimide, and positive tumour images were obtained by gamma camera imaging in eight patients with known lesions, and one previously undetected lesion was identified. True negative results were obtained in two patients without tumour. Area under the curve analysis of serial blood gamma counting and gamma camera images showed a higher tumour to blood ratio compared to A5B7 mF(ab′)2 used previously in the clinic, implying this new molecule may be superior for radioimmunotherapy. MIRD dose calculations showed a relatively high radiation dose to the kidney, which may limit the amount of activity that could be administered in radioimmunotherapy. However the reduction in immunogenicity was also a major advantage for A5B7 humanised divalent-Fab′ maleimide over murine versions of this antibody suggesting that humanised divalent-Fab′ maleimide should be a useful vehicle for repeated therapies." @default.
• W2051310287 created "2016-06-24" @default.
• W2051310287 creator A5007259776 @default.
• W2051310287 creator A5010881489 @default.
• W2051310287 creator A5021015559 @default.
• W2051310287 creator A5039832070 @default.
• W2051310287 creator A5040445316 @default.
• W2051310287 creator A5045048999 @default.
• W2051310287 creator A5047823545 @default.
• W2051310287 creator A5058361854 @default.
• W2051310287 creator A5082193559 @default.
• W2051310287 creator A5088611602 @default.
• W2051310287 creator A5089453687 @default.
• W2051310287 date "2002-05-01" @default.
• W2051310287 modified "2023-10-17" @default.
• W2051310287 title "Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study" @default.
• W2051310287 cites W10010671 @default.
• W2051310287 cites W1862541819 @default.
• W2051310287 cites W1893112022 @default.
• W2051310287 cites W1965321721 @default.
• W2051310287 cites W1971142781 @default.
• W2051310287 cites W1973838989 @default.
• W2051310287 cites W1982987387 @default.
• W2051310287 cites W1994957566 @default.
• W2051310287 cites W1998453285 @default.
• W2051310287 cites W2002492512 @default.
• W2051310287 cites W2030012565 @default.
• W2051310287 cites W2040505385 @default.
• W2051310287 cites W2042359007 @default.
• W2051310287 cites W2044809774 @default.
• W2051310287 cites W2046110140 @default.
• W2051310287 cites W2050634440 @default.
• W2051310287 cites W2067824099 @default.
• W2051310287 cites W2079187574 @default.
• W2051310287 cites W2089367263 @default.
• W2051310287 cites W2133644731 @default.
• W2051310287 cites W2175687390 @default.
• W2051310287 cites W228495852 @default.
• W2051310287 cites W2369882929 @default.
• W2051310287 cites W260507586 @default.
• W2051310287 cites W4229921932 @default.
• W2051310287 doi "https://doi.org/10.1038/sj.bjc.6600198" @default.
• W2051310287 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2375360" @default.
• W2051310287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11986771" @default.
• W2051310287 hasPublicationYear "2002" @default.
• W2051310287 type Work @default.
• W2051310287 sameAs 2051310287 @default.
• W2051310287 citedByCount "41" @default.
• W2051310287 countsByYear W20513102872012 @default.
• W2051310287 countsByYear W20513102872013 @default.
• W2051310287 countsByYear W20513102872015 @default.
• W2051310287 countsByYear W20513102872016 @default.
• W2051310287 countsByYear W20513102872017 @default.
• W2051310287 countsByYear W20513102872021 @default.
• W2051310287 countsByYear W20513102872022 @default.
• W2051310287 crossrefType "journal-article" @default.
• W2051310287 hasAuthorship W2051310287A5007259776 @default.
• W2051310287 hasAuthorship W2051310287A5010881489 @default.
• W2051310287 hasAuthorship W2051310287A5021015559 @default.
• W2051310287 hasAuthorship W2051310287A5039832070 @default.
• W2051310287 hasAuthorship W2051310287A5040445316 @default.
• W2051310287 hasAuthorship W2051310287A5045048999 @default.
• W2051310287 hasAuthorship W2051310287A5047823545 @default.
• W2051310287 hasAuthorship W2051310287A5058361854 @default.
• W2051310287 hasAuthorship W2051310287A5082193559 @default.
• W2051310287 hasAuthorship W2051310287A5088611602 @default.
• W2051310287 hasAuthorship W2051310287A5089453687 @default.
• W2051310287 hasBestOaLocation W20513102871 @default.
• W2051310287 hasConcept C159654299 @default.
• W2051310287 hasConcept C178790620 @default.
• W2051310287 hasConcept C185592680 @default.
• W2051310287 hasConcept C188027245 @default.
• W2051310287 hasConcept C203014093 @default.
• W2051310287 hasConcept C2776146153 @default.
• W2051310287 hasConcept C2780105360 @default.
• W2051310287 hasConcept C2780868878 @default.
• W2051310287 hasConcept C542903549 @default.
• W2051310287 hasConcept C71924100 @default.
• W2051310287 hasConcept C74884574 @default.
• W2051310287 hasConceptScore W2051310287C159654299 @default.
• W2051310287 hasConceptScore W2051310287C178790620 @default.
• W2051310287 hasConceptScore W2051310287C185592680 @default.
• W2051310287 hasConceptScore W2051310287C188027245 @default.
• W2051310287 hasConceptScore W2051310287C203014093 @default.
• W2051310287 hasConceptScore W2051310287C2776146153 @default.
• W2051310287 hasConceptScore W2051310287C2780105360 @default.
• W2051310287 hasConceptScore W2051310287C2780868878 @default.
• W2051310287 hasConceptScore W2051310287C542903549 @default.
• W2051310287 hasConceptScore W2051310287C71924100 @default.
• W2051310287 hasConceptScore W2051310287C74884574 @default.
• W2051310287 hasIssue "9" @default.
• W2051310287 hasLocation W20513102871 @default.
• W2051310287 hasLocation W20513102872 @default.
• W2051310287 hasLocation W20513102873 @default.
• W2051310287 hasLocation W20513102874 @default.
• W2051310287 hasOpenAccess W2051310287 @default.
• W2051310287 hasPrimaryLocation W20513102871 @default.
• W2051310287 hasRelatedWork W103969916 @default.

• next